\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ within\\ normal\\ limits\\ except\\ for\\ tenderness\\ throughout\\ the\\ abdomen\\ with\\ rebound\\.\\ on\\ pelvic\\ exam\\ cervical\\ motion\\ tenderness\\ was\\ absent\\;but\\,\\ there\\ is\\ a\\ mucopurulent\\ discharge\\ from\\ the\\ cervical\\ os\\.\ \(0\)\
\-\ labs\\:\\ \ \(3\)\
\-\ 1\\.lipase\\:\\ 2044\\(outside\\ facility\\)\\ down\\ to\\ 21\\ second\\ day\\ of\\ admission\\ \ \(0\)\
\-\ 2\\.amylase\\:125\ \(0\)\
\-\ 3\\.urinalysis\\:positive\\ for\\ leukocyte\\ esterase\ \(0\)\
\-\ 4\\.urine\\ culture\\:day\\ 1\\ grew\\ 30\\,000\\ \\-\\ 40\\,000\\ group\\ b\\ strep\ \(0\)\
\-\ pcr\\ for\\ chlamydia\\:positive\ \(0\)\
\-\ pcr\\ for\\ gonorrhea\\:positive\ \(0\)\
\-\ rpr\\:\\ non\\ reactive\ \(0\)\
\-\ hiv\\:\\ negative\ \(0\)\
\-\ bmp\\:\\ wnl\ \(0\)\
\-\ lipid\\ panel\\:\\ total\\ cholesterol\\:\\ 78\\,\\ tg\\ 42\\,\\ hdl\\ 30\\,\\ vldl\\ 8\ \(0\)\
\-\ mrcp\\ showed\\ no\\ signs\\ of\\ pancreatitis\\ \\-\\ but\\ with\\ fluid\\ in\\ the\\ pericholecystic\\ space\\ and\\ in\\ the\\ right\\ paracolic\\ gutter\\.\\ given\\ these\\ findings\\,\\ a\\ diagnosis\\ of\\ fitz\\-hugh\\-curtis\\ syndrome\\ was\\ established\\.\\ the\\ patient\\ was\\ started\\ on\\ iv\\ cefoxitine\\ and\\ po\\ doxycycline\\.\\ her\\ abdominal\\ pain\\ resolved\\ after\\ 24\\ hours\\ of\\ cefoxitine\\,\\ and\\ she\\ was\\ discharged\\ with\\ 12\\ days\\ remaining\\ of\\ 100mg\\ of\\ oral\\ doxycycline\\ twice\\ daily\\.\\ this\\ was\\ reported\\ to\\ the\\ county\\ health\\ board\\ to\\ try\\ to\\ get\\ hold\\ of\\ the\\ sexual\\ contacts\\.\\ no\\ follow\\-up\\ at\\ this\\ time\\.\ \(0\)\
\-\ u\\/s\\:\\ mildly\\ distended\\ common\\ bile\\ duct\\.borderline\\ to\\ mild\\ splenomegaly\\.\ \(0\)\
\-\ mrcp\\ without\\ contrast\\:\\ a\\ small\\ right\\ pleural\\ effusion\\ and\\ a\\ small\\ amount\\ of\\ fluid\\ in\\ the\\ pericholecystic\\ space\\ and\\ also\\ in\\ the\\ right\\ paracolic\\ gutter\\.\ \(0\)\
\-\ of\\ note\\ there\\ is\\ no\\ evidence\\ of\\ fluid\\ around\\ the\\ pancreas\\ or\\ a\\ pancreatic\\ pseudocyst\\.\\ the\\ pancreatic\\ duct\\ is\\ not\\ prominent\\ of\\ the\\ common\\ duct\\ is\\ slightly\\ prominent\\ at\\ 5\\ mm\\.\ \(0\)\
\-\ fitz\\-hugh\\ curtis\\ syndrome\ \(0\)\
\-\ 1\\.cholelithiasis\ \(0\)\
\-\ 2\\.cholecystitis\ \(0\)\
\-\ 3\\.pleurisy\ \(0\)\
\-\ 4\\.pneumonia\ \(0\)\
\-\ 5\\.pulmonary\\ embolism\ \(0\)\
\-\ 6\\.rib\\ fracture\ \(0\)\
\-\ 7\\.pyelonephritis\ \(0\)\
\-\ 8\\.hepatitis\ \(0\)\
\-\ 9\\.perforated\\ ulcer\ \(0\)\
\-\ 10\\.subphrenic\\ abscess\ \(0\)\
\-\ 11\\.pancreatitis\\ \\(gall\\ stone\\ pancreatitis\\)\ \(0\)\
\-\ 12\\.appendicitis\ \(0\)\
\-\ 13\\.herpes\\ zoster\ \(0\)\
\-\ 14\\.pid\ \(0\)\
\-\ 13\\ y\\.o\\.\\ girl\\ was\\ awakened\\ out\\ of\\ sleep\\ at\\ 2\\ am\\ by\\ a\\ sharp\\ 10\\/10\\ stabbing\\ pain\\ that\\ radiated\\ to\\ her\\ back\\.\\ she\\ denied\\ fevers\\,\\ rigors\\,\\ or\\ vomiting\\.\\ \\ the\\ pain\\ remains\\ constant\\ since\\ developing\\.\\ she\\ was\\ referred\\ from\\ an\\ outside\\ facility\\ with\\ a\\ diagnosis\\ of\\ pancreatitis\\,\\ because\\ her\\ labs\\ there\\ were\\ reported\\ to\\ be\\ abnormal\\.\\ \\ \\(the\\ lipase\\ was\\ 2044\\ and\\ the\\ amylase\\ 125\\,\\ \\ 10\\-15\\ wbcs\\ and\\ moderate\\ leukesterase\\ on\\ ua\\.\\)\\ \\ \\ there\\ is\\ a\\ family\\ history\\ of\\ gallbladder\\ disease\\,\\ she\\ denies\\ alcohol\\ use\\,\\ and\\ no\\ family\\ history\\ of\\ cystic\\ fibrosis\\.\\ \\ she\\ \\ is\\ sexually\\ active\\,\\ but\\ denies\\ dysuria\\,\\ polyuria\\,\\ diarrhea\\,\\ dyspareunia\\,\\ vaginal\\ discharge\\.\\ \\ her\\ last\\ menses\\ was\\ 1\\ week\\ ago\\ and\\ was\\ normal\\.\\ \\ she\\ has\\ had\\ two\\ sexual\\ partners\\,\\ and\\ the\\ last\\ coitus\\ episode\\ was\\ 2\\ weeks\\ ago\\.\\ \\ her\\ mother\\ has\\ cad\\ diagnosed\\ under\\ 50\\ y\\.o\\.\\ and\\ is\\ believed\\ to\\ have\\ hyperlipidemia\\.\ \(0\)\
\-\ with\\ the\\ initial\\ lipase\\ of\\ 2044\\ the\\ admitting\\ team\\ was\\ concerned\\ for\\ possible\\ gall\\ stone\\ pancreatitis\\.\\ however\\,\\ repeat\\ lipase\\ was\\ down\\ to\\ 66\\,\\ postive\\ pcr\\ for\\ gc\\ and\\ chlyamydia\\,\\ and\\ the\\ findings\\ of\\ mrcp\\ \\(done\\ to\\ evaluate\\ pancreatitis\\)\\ the\\ diagnosis\\ of\\ fitz\\-hugh\\ curtis\\ syndrome\\ was\\ made\\.\\ \\ http\\:\\/\\/emedicine\\.medscape\\.com\\/article\\/256448\\-overview\ \(0\)\
\-\ http\\:\\/\\/www\\.ncbi\\.nlm\\.nih\\.gov\\/pmc\\/articles\\/pmc2773862\\/\ \(0\)\
\-\ http\\:\\/\\/www\\.ccjm\\.org\\/content\\/71\\/3\\/233\\.long\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ 2044\\:\\ 0\\.050278622189922996\ \(0\)\
\-\ pancreatitis\\:\\ 0\\.044566388202674966\ \(0\)\
\-\ pcr\\:\\ 0\\.03610615080329942\ \(0\)\
\-\ mrcp\\:\\ 0\\.03564963345915377\ \(0\)\
\-\ \\:\\:\\ 0\\.034380982995913766\ \(0\)\
\-\ cefoxitine\\:\\ 0\\.03351908145994866\ \(0\)\
\-\ fitz\\-hugh\\:\\ 0\\.03351908145994866\ \(0\)\
\-\ curtis\\:\\ 0\\.030883540849454574\ \(0\)\
\-\ lipase\\:\\ 0\\.02984030124815811\ \(0\)\
\-\ doxycycline\\:\\ 0\\.027399545671225847\ \(0\)\
\-\ she\\:\\ 0\\.02736257956031375\ \(0\)\
\-\ paracolic\\:\\ 0\\.0267063078126937\ \(0\)\
\-\ was\\:\\ 0\\.026303964469565806\ \(0\)\
\-\ gutter\\:\\ 0\\.02476400506073176\ \(0\)\
\-\ sexual\\:\\ 0\\.02476400506073176\ \(0\)\
\-\ her\\:\\ 0\\.02442406519472372\ \(0\)\
\-\ gall\\:\\ 0\\.02128000988250303\ \(0\)\
\-\ pericholecystic\\:\\ 0\\.020586772023970884\ \(0\)\
\-\ http\\:\\ 0\\.018455068049317163\ \(0\)\
\-\ facility\\:\\ 0\\.017765717481273632\ \(0\)\
\-\ mucopurulent\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 1\\.lipase\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 2\\.amylase\\:125\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 3\\.urinalysis\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 4\\.urine\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 40\\,000\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ duct\\.borderline\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 1\\.cholelithiasis\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 2\\.cholecystitis\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 3\\.pleurisy\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 4\\.pneumonia\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 5\\.pulmonary\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 6\\.rib\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 7\\.pyelonephritis\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 8\\.hepatitis\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 9\\.perforated\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 10\\.subphrenic\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 11\\.pancreatitis\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 12\\.appendicitis\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 13\\.herpes\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 14\\.pid\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ leukesterase\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ partners\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ coitus\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ chlyamydia\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ \\/\\/emedicine\\.medscape\\.com\\/article\\/256448\\-overview\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ \\/\\/www\\.ncbi\\.nlm\\.nih\\.gov\\/pmc\\/articles\\/pmc2773862\\/\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ \\/\\/www\\.ccjm\\.org\\/content\\/71\\/3\\/233\\.long\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ stone\\:\\ 0\\.016164145370717347\ \(0\)\
\-\ pancreatic\\:\\ 0\\.015896537778467158\ \(0\)\
\-\ positive\\:\\ 0\\.015814936826715496\ \(0\)\
\-\ discharge\\:\\ 0\\.01575167144298324\ \(0\)\
\-\ fitz\\-hugh\\-curtis\\:\\ 0\\.015441770424727287\ \(0\)\
\-\ gc\\:\\ 0\\.015441770424727287\ \(0\)\
\-\ duct\\:\\ 0\\.014896116441123904\ \(0\)\
\-\ 30\\,000\\:\\ 0\\.014670924211593894\ \(0\)\
\-\ gonorrhea\\:\\ 0\\.014670924211593894\ \(0\)\
\-\ hdl\\:\\ 0\\.014670924211593894\ \(0\)\
\-\ vldl\\:\\ 0\\.014670924211593894\ \(0\)\
\-\ awakened\\:\\ 0\\.014670924211593894\ \(0\)\
\-\ 100mg\\:\\ 0\\.014124000119480243\ \(0\)\
\-\ county\\:\\ 0\\.014124000119480243\ \(0\)\
\-\ admitting\\:\\ 0\\.014124000119480243\ \(0\)\
\-\ down\\:\\ 0\\.013946859114650361\ \(0\)\
\-\ syndrome\\:\\ 0\\.01393863066578693\ \(0\)\
\-\ last\\:\\ 0\\.01388111197734975\ \(0\)\
\-\ fluid\\:\\ 0\\.013851553828539087\ \(0\)\
\-\ denies\\:\\ 0\\.013711149319867215\ \(0\)\
\-\ tg\\:\\ 0\\.013699772835612923\ \(0\)\
\-\ rigors\\:\\ 0\\.013699772835612923\ \(0\)\
\-\ dyspareunia\\:\\ 0\\.013699772835612923\ \(0\)\
\-\ postive\\:\\ 0\\.013699772835612923\ \(0\)\
\-\ outside\\:\\ 0\\.013628934627801945\ \(0\)\
\-\ prominent\\:\\ 0\\.013335554093404157\ \(0\)\
\-\ family\\:\\ 0\\.013316777357128178\ \(0\)\
\-\ sexually\\:\\ 0\\.013060091777397689\ \(0\)\
\-\ polyuria\\:\\ 0\\.013060091777397689\ \(0\)\
\-\ chlamydia\\:\\ 0\\.012806229814233197\ \(0\)\
\-\ try\\:\\ 0\\.012806229814233197\ \(0\)\
\-\ zoster\\:\\ 0\\.012806229814233197\ \(0\)\
\-\ stabbing\\:\\ 0\\.01238200253036588\ \(0\)\
\-\ hold\\:\\ 0\\.012200804469901383\ \(0\)\
\-\ ago\\:\\ 0\\.012094025934590299\ \(0\)\
\-\ rpr\\:\\ 0\\.012035383601099806\ \(0\)\
\-\ board\\:\\ 0\\.012035383601099806\ \(0\)\
\-\ cad\\:\\ 0\\.011883211153051257\ \(0\)\
\-\ reported\\:\\ 0\\.011844391066828183\ \(0\)\
\-\ cervical\\:\\ 0\\.011806431203770451\ \(0\)\
\-\ strep\\:\\ 0\\.011742321472150645\ \(0\)\
\-\ 10\\/10\\:\\ 0\\.011742321472150645\ \(0\)\
\-\ esterase\\:\\ 0\\.011611156317232486\ \(0\)\
\-\ 125\\:\\ 0\\.011611156317232486\ \(0\)\
\-\ wbcs\\:\\ 0\\.011611156317232486\ \(0\)\
\-\ u\\/s\\:\\ 0\\.011488459508986153\ \(0\)\
\-\ labs\\:\\ 0\\.01130028139519064\ \(0\)\
\-\ diagnosis\\:\\ 0\\.011191365004451065\ \(0\)\
\-\ leukocyte\\:\\ 0\\.011161747993916461\ \(0\)\
\-\ lipid\\:\\ 0\\.011064232225118835\ \(0\)\
\-\ splenomegaly\\:\\ 0\\.011064232225118835\ \(0\)\
\-\ 10\\-15\\:\\ 0\\.011064232225118835\ \(0\)\
\-\ contacts\\:\\ 0\\.010971475259017252\ \(0\)\
\-\ radiated\\:\\ 0\\.010971475259017252\ \(0\)\
\-\ menses\\:\\ 0\\.010971475259017252\ \(0\)\
\-\ concerned\\:\\ 0\\.010883034164654339\ \(0\)\
\-\ \\,\\:\\ 0\\.01080781630392212\ \(0\)\
\-\ space\\:\\ 0\\.010747365045918762\ \(0\)\
\-\ bmp\\:\\ 0\\.01071761329585276\ \(0\)\
\-\ dysuria\\:\\ 0\\.010565440847804213\ \(0\)\
\-\ grew\\:\\ 0\\.01049369117483302\ \(0\)\
\-\ pseudocyst\\:\\ 0\\.01049369117483302\ \(0\)\
\-\ but\\:\\ 0\\.010394505519202686\ \(0\)\
\-\ twice\\:\\ 0\\.01035783763114073\ \(0\)\
\-\ day\\:\\ 0\\.010315436613509237\ \(0\)\
\-\ cholesterol\\:\\ 0\\.010293386011985442\ \(0\)\
\-\ hyperlipidemia\\:\\ 0\\.010055433268726877\ \(0\)\
\-\ amylase\\:\\ 0\\.010000323883036281\ \(0\)\
\-\ established\\:\\ 0\\.00994676708271937\ \(0\)\
\-\ get\\:\\ 0\\.00994676708271937\ \(0\)\
\-\ constant\\:\\ 0\\.009894677778179227\ \(0\)\
\-\ tenderness\\:\\ 0\\.009881795904492903\ \(0\)\
\-\ 78\\:\\ 0\\.009843977688669415\ \(0\)\
\-\ believed\\:\\ 0\\.00974646191987179\ \(0\)\
\-\ team\\:\\ 0\\.00974646191987179\ \(0\)\
\-\ os\\:\\ 0\\.009699517789471845\ \(0\)\
\-\ there\\:\\ 0\\.009670840733574059\ \(0\)\
\-\ panel\\:\\ 0\\.009565263859407295\ \(0\)\
\-\ y\\.o\\:\\ 0\\.009377868564968441\ \(0\)\
\-\ po\\:\\ 0\\.009284587055593483\ \(0\)\
\-\ sleep\\:\\ 0\\.009211457244133796\ \(0\)\
\-\ hiv\\:\\ 0\\.009007568403157374\ \(0\)\
\-\ health\\:\\ 0\\.009007568403157374\ \(0\)\
\-\ ulcer\\:\\ 0\\.008944191178314043\ \(0\)\
\-\ sharp\\:\\ 0\\.008794417646273901\ \(0\)\
\-\ 66\\:\\ 0\\.00873766296347983\ \(0\)\
\-\ bile\\:\\ 0\\.008682553577789237\ \(0\)\
\-\ culture\\:\\ 0\\.008655586591112515\ \(0\)\
\-\ ua\\:\\ 0\\.008628996777472324\ \(0\)\
\-\ vaginal\\:\\ 0\\.008576907472932183\ \(0\)\
\-\ common\\:\\ 0\\.008502917155727745\ \(0\)\
\-\ rebound\\:\\ 0\\.008501355517324742\ \(0\)\
\-\ developing\\:\\ 0\\.008501355517324742\ \(0\)\
\-\ group\\:\\ 0\\.008452605649238549\ \(0\)\
\-\ remaining\\:\\ 0\\.008452605649238549\ \(0\)\
\-\ remains\\:\\ 0\\.008452605649238549\ \(0\)\
\-\ diarrhea\\:\\ 0\\.008428691614624746\ \(0\)\
\-\ daily\\:\\ 0\\.008405074656452583\ \(0\)\
\-\ am\\:\\ 0\\.008358703072566349\ \(0\)\
\-\ wnl\\:\\ 0\\.008335934648523164\ \(0\)\
\-\ for\\:\\ 0\\.008316822988319945\ \(0\)\
\-\ pancreas\\:\\ 0\\.008313435679612513\ \(0\)\
\-\ except\\:\\ 0\\.008226011509951251\ \(0\)\
\-\ 42\\:\\ 0\\.008226011509951251\ \(0\)\
\-\ alcohol\\:\\ 0\\.008183762200474617\ \(0\)\
\-\ to\\:\\ 0\\.008119165559752591\ \(0\)\
\-\ episode\\:\\ 0\\.008042872519574003\ \(0\)\
\-\ embolism\\:\\ 0\\.007948268889233579\ \(0\)\
\-\ denied\\:\\ 0\\.007911707364655846\ \(0\)\
\-\ resolved\\:\\ 0\\.00787583572149162\ \(0\)\
\-\ distended\\:\\ 0\\.007858150564338933\ \(0\)\
\-\ gallbladder\\:\\ 0\\.007806061259798791\ \(0\)\
\-\ 1\\:\\ 0\\.0077312789656262615\ \(0\)\
\-\ fevers\\:\\ 0\\.007722297020646642\ \(0\)\
\-\ reactive\\:\\ 0\\.0076897980979103294\ \(0\)\
\-\ b\\:\\ 0\\.007657845401491355\ \(0\)\
\-\ repeat\\:\\ 0\\.007642068209828435\ \(0\)\
\-\ small\\:\\ 0\\.007485077126924406\ \(0\)\
\-\ is\\:\\ 0\\.007482957126792926\ \(0\)\
\-\ discharged\\:\\ 0\\.007448058220561952\ \(0\)\
\-\ mother\\:\\ 0\\.007419892658232788\ \(0\)\
\-\ 21\\:\\ 0\\.007351251964996825\ \(0\)\
\-\ 13\\:\\ 0\\.007337816285865471\ \(0\)\
\-\ started\\:\\ 0\\.007246334825135055\ \(0\)\
\-\ fibrosis\\:\\ 0\\.0072336181176240345\ \(0\)\
\-\ admission\\:\\ 0\\.007159054024176732\ \(0\)\
\-\ exam\\:\\ 0\\.007137771634789118\ \(0\)\
\-\ under\\:\\ 0\\.0070990761577605236\ \(0\)\
\-\ absent\\:\\ 0\\.007040932767319306\ \(0\)\
\-\ 2\\:\\ 0\\.006996595043766336\ \(0\)\
\-\ total\\:\\ 0\\.006995665374365468\ \(0\)\
\-\ \\-\\:\\ 0\\.006964746991286554\ \(0\)\
\-\ mildly\\:\\ 0\\.006918951884776937\ \(0\)\
\-\ findings\\:\\ 0\\.006915729793878173\ \(0\)\
\-\ oral\\:\\ 0\\.006845214194596032\ \(0\)\
\-\ amount\\:\\ 0\\.006784209794308008\ \(0\)\
\-\ around\\:\\ 0\\.006764302380111629\ \(0\)\
\-\ done\\:\\ 0\\.006734826740309414\ \(0\)\
\-\ non\\:\\ 0\\.006715427177240513\ \(0\)\
\-\ limits\\:\\ 0\\.006696223572703434\ \(0\)\
\-\ pelvic\\:\\ 0\\.006667777046702079\ \(0\)\
\-\ 12\\:\\ 0\\.006649046445099395\ \(0\)\
\-\ at\\:\\ 0\\.006603211898279276\ \(0\)\
\-\ slightly\\:\\ 0\\.006566970072732077\ \(0\)\
\-\ evaluate\\:\\ 0\\.006566970072732077\ \(0\)\
\-\ no\\:\\ 0\\.006543301526264654\ \(0\)\
\-\ motion\\:\\ 0\\.006531598993205397\ \(0\)\
\-\ made\\:\\ 0\\.006471240251162468\ \(0\)\
\-\ use\\:\\ 0\\.006420986910728712\ \(0\)\
\-\ hours\\:\\ 0\\.006388207811043339\ \(0\)\
\-\ moderate\\:\\ 0\\.006388207811043339\ \(0\)\
\-\ 24\\:\\ 0\\.006316458138072148\ \(0\)\
\-\ pleural\\:\\ 0\\.006308650567819955\ \(0\)\
\-\ note\\:\\ 0\\.0062700865541859135\ \(0\)\
\-\ 30\\:\\ 0\\.006247318130142728\ \(0\)\
\-\ second\\:\\ 0\\.006239788850264216\ \(0\)\
\-\ vomiting\\:\\ 0\\.006202583344191788\ \(0\)\
\-\ active\\:\\ 0\\.006202583344191788\ \(0\)\
\-\ 50\\:\\ 0\\.006180604594379856\ \(0\)\
\-\ effusion\\:\\ 0\\.006173334449059698\ \(0\)\
\-\ referred\\:\\ 0\\.006130287915314907\ \(0\)\
\-\ has\\:\\ 0\\.006101520800358471\ \(0\)\
\-\ throughout\\:\\ 0\\.0060812686811785675\ \(0\)\
\-\ 8\\:\\ 0\\.006074367981462639\ \(0\)\
\-\ a\\:\\ 0\\.006031936149332339\ \(0\)\
\-\ mm\\:\\ 0\\.005973755050941075\ \(0\)\
\-\ diagnosed\\:\\ 0\\.005973755050941075\ \(0\)\
\-\ since\\:\\ 0\\.005967233121099271\ \(0\)\
\-\ pain\\:\\ 0\\.005952137837627765\ \(0\)\
\-\ iv\\:\\ 0\\.005928564519888011\ \(0\)\
\-\ signs\\:\\ 0\\.005717444741418354\ \(0\)\
\-\ girl\\:\\ 0\\.005711744165379844\ \(0\)\
\-\ because\\:\\ 0\\.005683494898452562\ \(0\)\
\-\ given\\:\\ 0\\.005569228883110918\ \(0\)\
\-\ week\\:\\ 0\\.005517139578570775\ \(0\)\
\-\ \\(\\:\\ 0\\.005493245066493236\ \(0\)\
\-\ possible\\:\\ 0\\.005471449085330936\ \(0\)\
\-\ \\)\\:\\ 0\\.005426142145348327\ \(0\)\
\-\ initial\\:\\ 0\\.0053832360138389886\ \(0\)\
\-\ out\\:\\ 0\\.005368923720263339\ \(0\)\
\-\ back\\:\\ 0\\.005359441702181516\ \(0\)\
\-\ showed\\:\\ 0\\.005326622182364443\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.005285241428596468\ \(0\)\
\-\ the\\:\\ 0\\.005256626794814669\ \(0\)\
\-\ right\\:\\ 0\\.005142386173633555\ \(0\)\
\-\ abscess\\:\\ 0\\.005136570806338911\ \(0\)\
\-\ normal\\:\\ 0\\.0050935834775631215\ \(0\)\
\-\ days\\:\\ 0\\.004979228699946725\ \(0\)\
\-\ negative\\:\\ 0\\.0048519394702944375\ \(0\)\
\-\ from\\:\\ 0\\.0048153449169361685\ \(0\)\
\-\ abdomen\\:\\ 0\\.004812517610067864\ \(0\)\
\-\ 5\\:\\ 0\\.0047531566966619076\ \(0\)\
\-\ cystic\\:\\ 0\\.004685613511885472\ \(0\)\
\-\ two\\:\\ 0\\.0046527209840608475\ \(0\)\
\-\ abnormal\\:\\ 0\\.004633255209724166\ \(0\)\
\-\ weeks\\:\\ 0\\.004610794214640966\ \(0\)\
\-\ time\\:\\ 0\\.004588595489048123\ \(0\)\
\-\ however\\:\\ 0\\.0045235134136826435\ \(0\)\
\-\ history\\:\\ 0\\.004487507747935679\ \(0\)\
\-\ and\\:\\ 0\\.004448891776651787\ \(0\)\
\-\ fracture\\:\\ 0\\.004283411274282849\ \(0\)\
\-\ mild\\:\\ 0\\.004278048391504062\ \(0\)\
\-\ evidence\\:\\ 0\\.0042593965463248624\ \(0\)\
\-\ these\\:\\ 0\\.0042278416196917116\ \(0\)\
\-\ on\\:\\ 0\\.004128655964061377\ \(0\)\
\-\ abdominal\\:\\ 0\\.004060682962209345\ \(0\)\
\-\ of\\:\\ 0\\.003986822080539528\ \(0\)\
\-\ physical\\:\\ 0\\.003985751463082202\ \(0\)\
\-\ \\;\\:\\ 0\\.0038506106244345886\ \(0\)\
\-\ without\\:\\ 0\\.0038251200881333843\ \(0\)\
\-\ or\\:\\ 0\\.0038080712888353897\ \(0\)\
\-\ were\\:\\ 0\\.0036887572940873027\ \(0\)\
\-\ this\\:\\ 0\\.0036545141190651447\ \(0\)\
\-\ contrast\\:\\ 0\\.003636455678342025\ \(0\)\
\-\ have\\:\\ 0\\.003517943114762532\ \(0\)\
\-\ had\\:\\ 0\\.0035054179073017266\ \(0\)\
\-\ after\\:\\ 0\\.003361219016367305\ \(0\)\
\-\ in\\:\\ 0\\.00320454167407038\ \(0\)\
\-\ also\\:\\ 0\\.0032026988472816566\ \(0\)\
\-\ within\\:\\ 0\\.003099109141418406\ \(0\)\
\-\ that\\:\\ 0\\.002806047012469246\ \(0\)\
\-\ by\\:\\ 0\\.0027050777628229556\ \(0\)\
\-\ disease\\:\\ 0\\.0026553945650488672\ \(0\)\
\-\ be\\:\\ 0\\.0025052409189048083\ \(0\)\
\-\ not\\:\\ 0\\.0023475640147185084\ \(0\)\
\-\ an\\:\\ 0\\.002246511148830285\ \(0\)\
\-\ \\.\\:\\ 0\\.001754729921161603\ \(0\)\
\-\ patient\\:\\ 0\\.001628501769803019\ \(0\)\
\-\ with\\:\\ 0\\.0011122069970521838\ \(0\)\
